Immunotherapy Drugs Market research report deals with many parameters in depth to satisfy the requirements of business or clients. Moreover, it also displays all the information including market definition, classifications, key developments, applications, and engagements along with the detailed actions of key players with respect to product launches, joint ventures, developments, mergers and acquisitions and effects of the same in terms of sales, import, export, revenue and CAGR values. A team of experienced and consummate market research professionals persistently track key industries to spot key developments, unmet needs and possible growth opportunities.
Immunotherapy Drugs Market, By Drug Type (Monoclonal Antibodies, Immunomodulators), By Indication (Infectious Diseases, Cancer) and by Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The global Immunotherapy Drugs Market size is projected to reach a CAGR of 11.7% from 2023-2030.
Download Free Sample Report at: https://www.delvens.com/get-free-sample/immunotherapy-drugs-market
Immunotherapy drugs are used to enhance or suppress the immune system of the body. They are mostly used in the treatment of cancer and act by stimulating the immune system of the body and generating an immune response aiding the production of antibodies. Antibodies produced against antigens kill the cancerous or tumour cells.
The global immunotherapy market is driven by the increasing adoption of targeted therapies, the increase in the life span of patients, and the high prevalence of lifestyle diseases. Furthermore, rapid approval of drugs and reduction in the recurrence of diseases propel market growth. Additionally, immunotherapy as an alternative to chemotherapy and the use of immunotherapy as the first line of drug for the treatment of cancer provide growth opportunities for the market players shortly.
Immunotherapy Drugs Market Competitive Landscape:
Amgen, Inc.
Novartis AG
AbbVie, Inc.
Pfizer, Inc.
- Hoffmann-La Roche Ltd.
Johnson & Johnson Services, Inc.
AstraZeneca
GSK
Sanofi
Bayer AG
Immunotherapy Drugs Market Recent Developments:
August 29, 2022 – AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology (EADV).
August 24, 2022 – AbbVie announced that the U.S. Food and Drug Administration (FDA) approved the use of IMBRUVICA® (ibrutinib) for the treatment of paediatric patients one year and older with chronic graft versus host disease (cGVHD) after the failure of one or more lines of systemic therapy.
Immunotherapy Drugs Market Key Findings:
Immunotherapy drugs are used to enhance or suppress the immune system of the body. They are mostly used in the treatment of cancer and act by stimulating the immune system of the body and generating an immune response aiding the production of antibodies. Antibodies produced against antigens kill the cancerous or tumour cells.
The indication segment is further fragmented into Cancer, Autoimmune Diseases, Infectious Diseases, and Others. The cancer segment accounted for the largest revenue share owing to the increased prevalence of cancer, coupled with a rise in the launch of cancer immunotherapies.
The drug type segment is further fragmented into monoclonal antibodies, immunomodulators, and vaccines. The monoclonal antibodies segment accounted for the largest share owing to increased R&D in therapeutic monoclonal antibodies coupled with supportive government initiatives.
The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America dominated the global industry and accounted for the largest share of the overall revenue. The launch and regulatory approval of new immunotherapy drugs and favourable reimbursement policies are projected to aid in the region’s growth.
Immunotherapy Drugs Market Regional Analysis:
North America to Dominate the Market
North America dominated the global industry and accounted for the largest share of the overall revenue.
The launch and regulatory approval of new immunotherapy drugs and favourable reimbursement policies are projected to aid in the region’s growth.
Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/immunotherapy-drugs-market
Scope of the Immunotherapy Drugs Market Report:
Immunotherapy Drugs Market is segmented into various segments such as drug type, indication, and region:
On the basis of drug type
Monoclonal Antibodies
Immunomodulators
Vaccines
On the basis of the indication
Cancer
Autoimmune Diseases
Infectious Diseases
Others
On the basis of region
Asia Pacific
North America
Europe
South America
Middle East & Africa
Frequently Asked Questions:
What are the years considered to study Immunotherapy Drugs Market?
What is the compound annual growth rate (CAGR) of the Immunotherapy Drugs Market?
Which region holds the largest market share in Immunotherapy Drugs Market?
Who are the major players in Immunotherapy Drugs Market?
Direct Purchase of the Immunotherapy Drugs Market Research Report at: https://www.delvens.com/checkout/immunotherapy-drugs-market
Browse Related Reports:
RNA-Sequencing (RNA-seq) & Analysis Market
Prostate Cancer Therapeutics Market
Relapsed/Refractory Multiple Myeloma (RRMM) Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055